Renata Gieroba

Renata Gieroba

Auto-generated profile, based on publicly available information

Renata Gieroba

Department of Laboratory Diagnostics, Medical University of Lublin, Poland

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2012 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JDJaroslaw Dudka
Jaroslaw Dudka
RGRenata Gieroba
Renata Gieroba
AKAgnieszka Korga
Agnieszka Korga
FBFranciszek Burdan
Franciszek Burdan
WMWlodzimierz Matysiak
Wlodzimierz Matysiak
Marek MuriasMarek Murias
Marek Murias
The aim of the study was to evaluate the effect of resveratrol in doxorubicin-induced cardiac and hepatic toxicity. Doxorubicin was administered once a week throughout the period of 7 weeks with 1.0 or 2.0 mg/kg body weight or concomitantly with resveratrol (20 mg/kg of feed). Heart and liver toxicity was histologically and biochemically evaluated. Resveratrol protected from the heart lipid peroxidation caused by 1 mg doxorubicin and it sharply diminished superoxide dismutase activity. An insignificant effect of resveratrol on the lipid peroxidation level and the superoxide dismutase activity was observed in the hearts of rats administered a higher dose of doxorubicin. However, resveratrol attenuate necrosis and other cardiac histopathological changes were induced by a high dose of doxorubicin. Interestingly, it slightly intensified adverse cardiac histological changes in rats receiving a lower dose of doxorubicin. Resveratrol did not have any protective effect on the hepatic oxidative stress, while exerting a mild beneficial effect on the morphological changes caused by doxorubicin. All in all, this study has shown different effects of resveratrol on dose-related doxorubicin-induced heart and liver toxicity. Resveratrol may modulate the hepatic and cardiac effect of doxorubicin, depending on the drug dose.

1 December 2017 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
MIMagdalena Izdebska
Magdalena Izdebska
IPIwona Piątkowska-Chmiel
Iwona Piątkowska-Chmiel
AKAgnieszka Korolczuk
Agnieszka Korolczuk
Mariola HerbetMariola Herbet
Mariola Herbet
MGMonika Gawronska-Grzywacz
Monika Gawronska-Grzywacz
JDJarosław Dudka
Jarosław Dudka
Nonalcoholic fatty liver disease (NAFLD) is currently one of the most common chronic liver diseases, especially in developed countries. One group of substances with a potential use in the treatment of NAFLD are plant polyphenols, represented by resveratrol. The aim of this study was to evaluate the effect of resveratrol on steatosis and oxidative stress in HepG2 cells. The steatosis of cells was carried out using free fatty acids: oleic or palmitic acid and their mixtures. Steatosis was visualized using the intracellular lipid staining by Nile Red dye with a fluorescence microscope. This study also determined the viability of cells and mitochondrial membrane potential. The current study showed that fatty acids and their mixtures induced fat overloading in HepG2 cells. In the group of cells incubated with oleic acid (OA), observed changes were moderate with prevailing micro-vesicular steatosis. In case of cells incubated with palmitic acid (PA) and the mixtures of fatty acids, micro- and macro-vacuolar steatosis occurred in most of the cells. Resveratrol decreased steatosis in HepG2 cells induced by OA, PA, as well as their mixtures, and in most of experimental groups did not reduce cells viability. Resveratrol reduced the oxidative stress in HepG2 cells treated with fatty acids mixtures.

6 November 2019 in FEBS Open Bio
Verified
Journal Article
Open access
PDF file
MKMalgorzata Kozyra
Malgorzata Kozyra
AKAgnieszka Korga-Plewko
Agnieszka Korga-Plewko
MOMarta Ostrowska-Lesko
Marta Ostrowska-Lesko
EHEwelina Humeniuk
Ewelina Humeniuk
GAGrzegorz Adamczuk
Grzegorz Adamczuk
JDJaroslaw Dudka
Jaroslaw Dudka
The Marrubium genus (horehound) has proved to be an abundant source of biologically active compounds, but there is little knowledge about its potential anticancer activity. Moreover, some Marrubium species have not been the subject of study in this regard. In this study, we performed comparative analysis of phenolic acid (PhA) content and total phenolic content in fractions obtained from methanolic extracts of Marrubium vulgare L. (common horehound), Marrubium cylleneum Boiss. & Heldr. and Marrubium friwaldskyanum Boiss herbs. We examined the cytotoxicity of these fractions against a human melanoma cancer cell line (A375) and normal human skin fibroblasts (BJ) using a 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐tetrazolium bromide test, cell cycle analysis and real‐time monitoring of cell viability. We detected caffeic, p‐coumaric, ferulic and gentisic acids among the PhAs. Although the extracts obtained demonstrated low total phenolic content and did not show significant antioxidative properties, the nonhydrolyzed PhA fraction exhibited cytotoxic activity against a human melanoma cancer cell line, without affecting normal fibroblasts. Both acidic and alkaline hydrolysis abolished this activity, indicating that the esterified forms of phenolic compounds caused the observed cytotoxic effects. Further investigation of these compounds may facilitate the development of novel drugs for cancer treatment.

1 February 2013 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
Elwira SieniawskaElwira Sieniawska
Elwira Sieniawska
TBTomasz Baj
Tomasz Baj
JDJarosław Dudka
Jarosław Dudka
RGRenata Gieroba
Renata Gieroba
Łukasz ŚwiątekŁukasz Świątek
Łukasz Świątek
Małgorzata Polz-DacewiczMałgorzata Polz-Dacewicz
Małgorzata Polz-Dacewicz

19 January 2015 in Food & Nutrition Research
Verified
Journal Article
Open access
PDF file
SMSlawomir Mandziuk
Slawomir Mandziuk
RGRenata Gieroba
Renata Gieroba
AKAgnieszka Korga
Agnieszka Korga
WMWlodzimierz Matysiak
Wlodzimierz Matysiak
BJBarbara Jodłowska-Jędrych
Barbara Jodłowska-Jędrych
JDJaroslaw Dudka
Jaroslaw Dudka
The differential effects of green tea on dose-dependent doxorubicin toxicity

1 November 2005 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
PDF file
JDJaroslaw Dudka
Jaroslaw Dudka
FBFranciszek Burdan
Franciszek Burdan
JSJustyna Szumilo
Justyna Szumilo
ETEdyta Tokarska
Edyta Tokarska
AKAgnieszka Korobowicz
Agnieszka Korobowicz
EKElzbieta Korobowicz
Elzbieta Korobowicz